104 related articles for article (PubMed ID: 1426249)
21. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
22. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
23. Functional interference between AP-1 and the vitamin D receptor on osteocalcin gene expression in human osteosarcoma cells.
Jääskeläinen T; Pirskanen A; Ryhänen S; Palvimo JJ; Deluca HF; Mäenpää PH
Eur J Biochem; 1994 Aug; 224(1):11-20. PubMed ID: 8076631
[TBL] [Abstract][Full Text] [Related]
24. Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation.
Nadori F; Lardeux B; Rahmani M; Bringuier A; Durand-Schneider AM; Bernuau D
Hepatology; 1997 Dec; 26(6):1477-83. PubMed ID: 9397987
[TBL] [Abstract][Full Text] [Related]
25. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
26. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
27. Sequential actions of ERK1/2 on the AP-1 transcription factor allow temporal integration of metabolic signals in pancreatic beta cells.
Glauser DA; Schlegel W
FASEB J; 2007 Oct; 21(12):3240-9. PubMed ID: 17504975
[TBL] [Abstract][Full Text] [Related]
28. Renewed DNA synthesis in senescent WI-38 cells by expression of an inducible chimeric c-fos construct.
Phillips PD; Pignolo RJ; Nishikura K; Cristofalo VJ
J Cell Physiol; 1992 Apr; 151(1):206-12. PubMed ID: 1560044
[TBL] [Abstract][Full Text] [Related]
29. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
Dosch J; Kaina B
Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
[TBL] [Abstract][Full Text] [Related]
30. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.
Angel P; Karin M
Biochim Biophys Acta; 1991 Dec; 1072(2-3):129-57. PubMed ID: 1751545
[No Abstract] [Full Text] [Related]
31. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest.
Yu W; Sanders BG; Kline K
Nutr Cancer; 1997; 27(1):92-101. PubMed ID: 8970189
[TBL] [Abstract][Full Text] [Related]
32. Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth.
Wu K; Liu M; Li A; Donninger H; Rao M; Jiao X; Lisanti MP; Cvekl A; Birrer M; Pestell RG
Mol Biol Cell; 2007 Mar; 18(3):755-67. PubMed ID: 17182846
[TBL] [Abstract][Full Text] [Related]
33. c-fos and c-jun mRNA expression in activated cord and adult lymphocytes: an analysis by Northern hybridization.
DePalma L; Brown E; Baker R
Vox Sang; 1998; 75(2):134-8. PubMed ID: 9784667
[TBL] [Abstract][Full Text] [Related]
34. Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun.
Leonard DA; Rajaram N; Kerppola TK
Proc Natl Acad Sci U S A; 1997 May; 94(10):4913-8. PubMed ID: 9144164
[TBL] [Abstract][Full Text] [Related]
35. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
Su ZZ; Yemul S; Stein CA; Fisher PB
Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
[TBL] [Abstract][Full Text] [Related]
36. Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation.
Gedrich RW; Bayley ST; Engel DA
J Virol; 1992 Oct; 66(10):5849-59. PubMed ID: 1326646
[TBL] [Abstract][Full Text] [Related]
37. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
38. Formation of AP1 transcriptional complex in concanavalin A-stimulated splenocytes derived from young and old mice.
Sikora E; Kaminska B; Kaczmarek L
Ann N Y Acad Sci; 1992 Nov; 663():458-9. PubMed ID: 1482086
[No Abstract] [Full Text] [Related]
39. Sphingosine 1-phosphate, a novel signaling molecule, stimulates DNA binding activity of AP-1 in quiescent Swiss 3T3 fibroblasts.
Su Y; Rosenthal D; Smulson M; Spiegel S
J Biol Chem; 1994 Jun; 269(23):16512-7. PubMed ID: 8206962
[TBL] [Abstract][Full Text] [Related]
40. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
